Olfr536 Inhibitors
Chemical inhibitors of Olfr536 function by targeting and blocking various ion channels that play a crucial role in the signal transduction pathways of olfactory neurons. Capsazepine, a TRPV1 antagonist, prevents calcium influx through TRPV1 channels, which are essential for the activation of neuronal responses that may involve Olfr536. Other chemicals that target TRPV1, such as BCTC, AMG-9810, JNJ-17203212, Iodo-Resiniferatoxin, and SB-705498, similarly inhibit Olfr536 by blocking these calcium channels, thereby interrupting the receptor's signal transduction pathways. These inhibitors bind to the TRPV1 channels and prevent the transduction of sensory signals that Olfr536 is associated with, effectively reducing its ability to function within the olfactory system.
Additional chemical inhibitors impact Olfr536 by antagonizing other transient receptor potential (TRP) channels. HC-030031 and A-967079, as selective TRPA1 antagonists, disrupt the chemosensory transduction in olfactory neurons by blocking TRPA1 channels, which can indirectly inhibit Olfr536. AP18, another TRPA1 antagonist, also impedes the signaling pathways that involve Olfr536 by obstructing TRPA1-mediated sensory transduction. Inhibitors like ML204 and SKF-96365 target TRPC channels, with ML204 specifically inhibiting TRPC4 and TRPC5 channels and SKF-96365 inhibiting receptor-mediated calcium entry channels, including TRPC channels. These actions result in the indirect inhibition of Olfr536 by modifying the ionic currents and signaling pathways necessary for its function. Ruthenium Red complements these inhibitors by its broad-spectrum inhibition of calcium channels, including TRPV channels, which further contributes to the inhibition of calcium-dependent signaling mechanisms important for Olfr536 activation and signal transduction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
Capsazepine is a synthetic compound that serves as a selective TRPV1 receptor antagonist. Olfr536, as an olfactory receptor, could be indirectly inhibited by Capsazepine through the blockade of TRPV1 channels, which are integral in certain olfactory signaling pathways that rely on calcium influx for the initiation of neuronal responses. | ||||||
HC-030031 | 349085-38-7 | sc-203994 sc-203994A | 10 mg 50 mg | $89.00 $333.00 | 2 | |
HC-030031 is a TRPA1 channel antagonist known to inhibit the function of these channels. Since TRPA1 channels can be part of the chemosensory transduction in olfactory neurons, the inhibition of TRPA1 by HC-030031 can indirectly inhibit Olfr536 by disrupting the transduction of sensory signals that Olfr536 is involved in. | ||||||
A-967079 | 1170613-55-4 | sc-363348 sc-363348A sc-363348B | 5 mg 25 mg 100 mg | $88.00 $372.00 $942.00 | 5 | |
A-967079 is another selective antagonist of the TRPA1 receptor. By inhibiting TRPA1 channels, A-967079 can impede the sensory signaling pathways involving Olfr536, leading to its functional inhibition, as the receptor's activity may be contingent on TRPA1-mediated effects. | ||||||
4-Methyl-2-(1-piperidinyl)-quinoline | 5465-86-1 | sc-483337 | 25 mg | $430.00 | ||
ML204 is an inhibitor of the TRPC4/TRPC5 channels. These channels are involved in the cellular mechanisms underlying various sensory transductions. Inhibition of TRPC channels by ML204 can indirectly inhibit Olfr536 by modulating the ionic currents and signaling pathways that are necessary for the proper functioning of olfactory receptors like Olfr536. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
SKF-96365 is an inhibitor of receptor-mediated calcium entry channels, including TRPC channels. By inhibiting these channels, SKF-96365 can indirectly inhibit Olfr536 by altering the calcium signaling that is necessary for the activation and function of olfactory receptors. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Ruthenium Red is a polycationic dye that inhibits calcium channels including TRPV channels. By inhibiting these channels, Ruthenium Red can indirectly inhibit Olfr536 by blocking the calcium-dependent signaling mechanisms that are crucial for the activation of olfactory receptors and their subsequent signal transduction. | ||||||
AMG-9810 | 545395-94-6 | sc-201477 sc-201477A | 10 mg 50 mg | $86.00 $344.00 | 3 | |
AMG-9810 is a selective TRPV1 antagonist. The inhibition of TRPV1 channels by AMG-9810 can indirectly inhibit Olfr536 by preventing TRPV1-mediated signal transduction pathways, which may be essential for the sensory signaling functions of Olfr536. | ||||||
JNJ 17203212 | 821768-06-3 | sc-204024 sc-204024A | 10 mg 50 mg | $185.00 $781.00 | ||
JNJ-17203212 is a TRPV1 antagonist that can indirectly inhibit Olfr536 by impeding the calcium-ion channels integral to the signal transduction pathways in which Olfr536 participates. By blocking TRPV1, JNJ-17203212 can disrupt the sensory signaling that Olfr536 is associated with. | ||||||